These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 10963601)
1. The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Coopman PJ; Do MT; Barth M; Bowden ET; Hayes AJ; Basyuk E; Blancato JK; Vezza PR; McLeskey SW; Mangeat PH; Mueller SC Nature; 2000 Aug; 406(6797):742-7. PubMed ID: 10963601 [TBL] [Abstract][Full Text] [Related]
2. Syk: a new player in the field of breast cancer. Stewart ZA; Pietenpol JA Breast Cancer Res; 2001; 3(1):5-7. PubMed ID: 11250739 [TBL] [Abstract][Full Text] [Related]
3. Progressive loss of Syk and abnormal proliferation in breast cancer cells. Moroni M; Soldatenkov V; Zhang L; Zhang Y; Stoica G; Gehan E; Rashidi B; Singh B; Ozdemirli M; Mueller SC Cancer Res; 2004 Oct; 64(20):7346-54. PubMed ID: 15492255 [TBL] [Abstract][Full Text] [Related]
4. Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer. Wang L; Duke L; Zhang PS; Arlinghaus RB; Symmans WF; Sahin A; Mendez R; Dai JL Cancer Res; 2003 Aug; 63(15):4724-30. PubMed ID: 12907655 [TBL] [Abstract][Full Text] [Related]
5. Growth-related oncogene produced in human breast cancer cells and regulated by Syk protein-tyrosine kinase. Li J; Sidell N Int J Cancer; 2005 Oct; 117(1):14-20. PubMed ID: 15880583 [TBL] [Abstract][Full Text] [Related]
6. A critical role for Syk in endothelial cell proliferation and migration. Inatome R; Yanagi S; Takano T; Yamamura H Biochem Biophys Res Commun; 2001 Aug; 286(1):195-9. PubMed ID: 11485328 [TBL] [Abstract][Full Text] [Related]
7. Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression. Wang L; Devarajan E; He J; Reddy SP; Dai JL Cancer Res; 2005 Nov; 65(22):10289-97. PubMed ID: 16288017 [TBL] [Abstract][Full Text] [Related]
8. Hypermethylation leads to silencing of the SYK gene in human breast cancer. Yuan Y; Mendez R; Sahin A; Dai JL Cancer Res; 2001 Jul; 61(14):5558-61. PubMed ID: 11454707 [TBL] [Abstract][Full Text] [Related]
9. Syk, a protein-tyrosine kinase, suppresses the cell motility and nuclear factor kappa B-mediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3'-kinase activity in breast cancer cells. Mahabeleshwar GH; Kundu GC J Biol Chem; 2003 Feb; 278(8):6209-21. PubMed ID: 12477728 [TBL] [Abstract][Full Text] [Related]
10. [Expression of tyrosine kinase Syk in breast cancer and their clinical significance]. Ding YB; Wu ZY; Wang S; Fan P; Zha XM; Zheng W; Liu XA Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):137-9. PubMed ID: 15062056 [TBL] [Abstract][Full Text] [Related]
11. Reactivation of SYK expression by inhibition of DNA methylation suppresses breast cancer cell invasiveness. Yuan Y; Liu H; Sahin A; Dai JL Int J Cancer; 2005 Feb; 113(4):654-9. PubMed ID: 15455373 [TBL] [Abstract][Full Text] [Related]
12. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Turner M; Mee PJ; Costello PS; Williams O; Price AA; Duddy LP; Furlong MT; Geahlen RL; Tybulewicz VL Nature; 1995 Nov; 378(6554):298-302. PubMed ID: 7477352 [TBL] [Abstract][Full Text] [Related]
13. CD45 is essential for Fc epsilon RI signaling by ZAP70, but not Syk, in Syk-negative mast cells. Zhang J; Siraganian RP J Immunol; 1999 Sep; 163(5):2508-16. PubMed ID: 10452987 [TBL] [Abstract][Full Text] [Related]
14. Sporadic mutations and expression analysis of spleen tyrosine kinase gene in breast cancer: a preliminary report. Inayat U; Kayani MA; Faryal R Pol J Pathol; 2012 Jun; 63(2):106-11. PubMed ID: 22864779 [TBL] [Abstract][Full Text] [Related]
15. The ectopic expression of IFN regulatory factor 4-binding protein is correlated with the malignant behavior of human breast cancer cells. Li P; Zhang Z; Wang Q; Li S; Zhang Y; Bian X; Chen A; Hu C Int Immunopharmacol; 2009 Jul; 9(7-8):1002-9. PubMed ID: 19393345 [TBL] [Abstract][Full Text] [Related]
16. [Hypermethylation of syk gene in promoter region is associated with oncogenesis, metastasis of breast carcinoma]. Ding YB; Wu ZY; Wang S; Zha XM; Zheng W; Liu XA; Fan P Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):290-3. PubMed ID: 15059510 [TBL] [Abstract][Full Text] [Related]
17. Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer. Toyama T; Iwase H; Yamashita H; Hara Y; Omoto Y; Sugiura H; Zhang Z; Fujii Y Cancer Lett; 2003 Jan; 189(1):97-102. PubMed ID: 12445683 [TBL] [Abstract][Full Text] [Related]
18. [Regulatory role of Syk gene on vascular endothelial growth factor C expression in breast cancer]. Chen XL; Li L; Zhang YJ Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):805-9. PubMed ID: 22336204 [TBL] [Abstract][Full Text] [Related]
19. Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling. Chan AC; van Oers NS; Tran A; Turka L; Law CL; Ryan JC; Clark EA; Weiss A J Immunol; 1994 May; 152(10):4758-66. PubMed ID: 8176201 [TBL] [Abstract][Full Text] [Related]
20. Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma. Rinaldi A; Kwee I; Taborelli M; Largo C; Uccella S; Martin V; Poretti G; Gaidano G; Calabrese G; Martinelli G; Baldini L; Pruneri G; Capella C; Zucca E; Cotter FE; Cigudosa JC; Catapano CV; Tibiletti MG; Bertoni F Br J Haematol; 2006 Feb; 132(3):303-16. PubMed ID: 16409295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]